Package Leaflets (PL) for Human medicinal products

The package leaflet (PL) provides users with information about the medicinal product and its correct use. The package leaflets contain instructions in both Finnish and Swedish.

The package leaflets can be searched from alphabetical list, with the name, marketing authorisation number and the Anatomical Therapeutic Chemical, i.e. ATC Code of the Summary of Product Characteristics, SPC.

The package leaflets processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Search with the first character of the name of the medicinal product: g

Product Information Leaflets 1 - 30 of 121
1  2  3  4  5  |  Next 30   >
SPC	Status for supply	Name of the medicinal product
SPC	Resepti	Gabapentin Accord 300 mg, 400 mg kapseli, kova PL 2023-06-14
SPC	Resepti	Gabapentin Accord 600 mg ja 800 mg tabletti, kalvopäällysteinen PL 2023-02-02
SPC	Resepti	Gabapentin Actavis 300 mg, 400 mg kapseli, kova PL 2024-02-05
SPC	Resepti	Gabapentin Actavis 600 mg, 800 mg tabletti, kalvopäällysteinen PL 2024-09-06
SPC	Resepti	Gabapentin Orion 300 mg, 400 mg kapseli, kova PL 2023-10-17
SPC	Resepti	Gabapentin Orion 600 mg, 800 mg tabletti, kalvopäällysteinen PL 2024-08-06
SPC	Resepti	Gabapentin ratiopharm 300 mg, 400 mg kapseli, kova PL 2024-08-22
SPC	Resepti	Gabapentin Sandoz 300 mg, 400 mg kapseli, kova PL 2023-11-22
SPC	Resepti	Gabapentin Sandoz 600 mg, 800 mg tabletti, kalvopäällysteinen PL 2023-03-27
SPC	Resepti	Gabapentin Strides 100 mg, 300 mg, 400 mg kapseli, kova PL 2024-09-02
SPC	Resepti	Gabrion 300 mg, 400 mg kapseli, kova PL 2023-10-20
SPC	Resepti	Gabrion 600 mg, 800 mg tabletti, kalvopäällysteinen PL 2023-10-20
SPC	Resepti	Gadovist 1 mmol-ml injektioneste, liuos PL 2024-10-02
SPC	Resepti	Gadovist 1 mmol-ml injektioneste, liuos, esitäytetty ruisku PL 2024-10-02
SPC	Resepti	Galafix 4, 8, 12 mg, tabletti SPC 2009-10-01
		European Medicines Agency's website: Galafold - EMA: EPAR PI Finnish Swedish
SPC	Resepti	Galantamin Krka 8 mg, 16 mg, 24 mg depotkapseli, kova PL 2022-04-28
SPC	Resepti	Galantamin Mylan 8, 16, 24 mg depotkapseli PL 2016-03-07
SPC	Resepti	Galantamin Orion 8 mg, 16 mg, 24 mg depotkapseli, kova PL 2023-03-03
SPC	Resepti	Galantamin STADA 8, 16, 24 mg depotkapseli PL 2021-01-18
SPC	Itsehoito	Galieve 500-213-325 mg oraalisuspensio PL 2020-05-12
SPC	Itsehoito	Galieve Mint oraalisuspensio PL 2021-03-16
SPC	Itsehoito	Galieve Mint oraalisuspensio, annospussi PL 2022-05-02
SPC	Itsehoito	Galieve Peppermint purutabletti PL 2021-02-16
SPC	Resepti	Galli Ad, 0,74-1,85 GBq, radionuklidigeneraattori, PL 2018-05-15
		European Medicines Agency's website: GalliaPharm - EMA: EPAR PI Finnish Swedish
SPC	Resepti	GalliaPharm 0.74-1.85 GBq radionuklidigeneraattori PL 2019-12-19
		European Medicines Agency's website: Galvus - EMA: EPAR PI Finnish Swedish
SPC	Resepti	Gammagard S-D infuusiokuiva-aine ja liuotin, liuosta varten PL
SPC	Resepti	Gamunex 100 mg-ml infuusioneste, liuos PL 2022-10-24
1  2  3  4  5  |  Next 30   >